BioDelivery Sciences to Report Second Quarter 2021 Financial Results on August 4, 2021

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) is a commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions.